Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME

Cancer Discov. 2024 Apr 4;14(4):643-647. doi: 10.1158/2159-8290.CD-23-1543.

Abstract

Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.

MeSH terms

  • Humans
  • Neoplasms* / therapy
  • Tumor Microenvironment